Dexcom has announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will launch in the United States on Dec. 1.

Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors ...

Routine continuous glucose monitoring (CGM) use offers the greatest hemoglobin A1c reductions for patients with type 2 diabetes.

Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

Ultrahuman, best known for its smart rings, has launched its continuous glucose monitor in the US. The device was first released in the UK in June 2021. The Ultrahuman M1 CGM can be purchased with a ...

Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of ...

A new report has found continuous glucose monitoring (CGM) may help reduce staff burden in the intensive care unit (ICU) by reducing the need for blood gas monitoring. Continuous glucose monitoring ...

Women with gestational diabetes continue to have adverse pregnancy outcomes that are often related to hyperglycaemia.

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology on adults with type 2 diabetes who are not treated with insulin. In one ...

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (CGM), is happy to share that people with type 1 diabetes who are 25 ...

Frequent use vs nonuse of a continuous glucose monitoring device is associated with improved long-term glycemic control in ...

The "United States Continuous Glucose Monitoring Market Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. The United States Continuous Glucose Monitoring (CGM) Market is ...